QA: Intellia Therapeutics Inc. in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001652130_2023_Intellia_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001652130, Intellia Therapeutics Inc.

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 126,554,000
2 remainder_Liabilities 0
3 AssetsCurrent 1,216,797,000
4 AssetsNoncurrent 234,869,000
5 PropertyPlantAndEquipmentNet 27,921,000
6 Goodwill 0
7 remainder_Assets 40,527,000
8 GeneralAndAdministrativeExpense 90,306,000
9 ResearchAndDevelopmentExpense 419,979,000
10 remainder_Expenses 0
11 remainder_Revenues 52,121,000
12 remainder_NetIncome -16,022,000
13 remainder_ComprehensiveNetIncome -4,829,000
  yvar yval
0 Liabilities 126,554,000
1 Assets 1,520,114,000
2 Expenses 510,285,000
3 Revenues 52,121,000
4 StockholdersEquity 1,393,560,000
5 NetIncome -474,186,000
6 ComprehensiveNetIncome -476,600,500
7 BaseVar 1,114,962,500
8 EconomicCapitalRatio 0.860

Edgar->Model Mapping

Feature Distribution

Change over Time